Lucchino David L. 4
4 · Korro Bio, Inc. · Filed Nov 22, 2023
Insider Transaction Report
Form 4
Korro Bio, Inc.KRRO
Lucchino David L.
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2023-11-03+5,600→ 18,274 total - Award
Common Stock
2023-11-03+6,000→ 24,274 total - Sale
Common Stock
2023-11-10$39.59/sh−373$14,767→ 23,864 total - Sale
Common Stock
2023-11-10$46.23/sh−34$1,572→ 23,306 total - Sale
Common Stock
2023-11-10$37.92/sh−37$1,403→ 24,237 total - Sale
Common Stock
2023-11-10$41.94/sh−41$1,720→ 23,823 total - Sale
Common Stock
2023-11-10$45.53/sh−67$3,050→ 23,340 total - Exercise/Conversion
Restricted Stock Units
2023-11-03−5,600→ 0 total→ Common Stock (5,600 underlying) - Sale
Common Stock
2023-11-10$43.17/sh−225$9,714→ 23,598 total - Sale
Common Stock
2023-11-10$44.01/sh−191$8,407→ 23,407 total
Footnotes (10)
- [F1]Reflects shares of the Issuer's common stock received upon vesting of restricted stock units ("RSUs") granted January 26, 2023 as adjusted for a 1-for-50 reverse stock split effected by the Issuer on November 3, 2023.
- [F10]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.07 to $46.00, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.
- [F2]Total number of shares of common stock is adjusted for a 1-for-50 reverse stock split effected by the Issuer on November 3, 2023.
- [F3]Reflects shares of the Issuer's common stock received upon execution of a separation agreement effective November 3, 2023 resulting in vesting of performance RSUs granted April 11, 2022, as adjusted for the 1-for-50 reverse stock split effected by the Issuer on November 3, 2023.
- [F4]Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs, and does not represent a discretionary trade by the Reporting Person.
- [F5]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.575 to $37.955, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.
- [F6]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.155 to $40.00, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.
- [F7]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.45 to $42.00, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.
- [F8]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.75 to $43.625, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.
- [F9]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.87 to $44.175, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.